A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
IDEAYA Biosciences
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Azienda Ospedaliero-Universitaria di Parma
NeoTX Therapeutics Ltd.
Actym Therapeutics, Inc.
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Cancer Research UK
Massachusetts General Hospital
Jules Bordet Institute
Quadriga Biosciences, Inc.
Augusta University
MacroGenics
Shionogi Inc.
Abramson Cancer Center at Penn Medicine
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
University of Chicago
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)